New scanning technology could reduce number of biopsies on people with fatty liver disease

By EASL February 16,2018

A study jointly led by the University of Birmingham and University of Edinburgh has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease. The authors of the study, also carried out in collaboration with the Universities of Liverpool and Oxford, concluded that 458 out of every 1,000 liver biopsies could be avoided if people are first assessed using scanning technology.

To read the full article, visit: News Medical